Concepedia

Tommaso Sconocchia

TS

Statistics

Publications

7

Citations

169

H-Index

7

Active since

2015

Affiliations

Medical University of Graz(Current)

Harvard University

Istituto di Farmacologia Traslazionale

University of Rome Tor Vergata

Medical University of Vienna

Tommaso Sconocchia is an author at Medical University of Graz specializing in cancer immunotherapy, pharmacology, and immunotherapy.

ORCID

Publications per year

2015–2023

7

Publications

7

<i>In vitro</i> elimination of epidermal growth factor receptor‐overexpressing cancer cells by CD32A‐chimeric receptor T cells in combination with cetuximab or panitumumab

Sara Caratelli, Roberto Arriga, Tommaso Sconocchia et al. · International Journal of Cancer · 2019 · 43 citations · Full text

, , +17

CD16‐158‐valine chimeric receptor T cells overcome the resistance of KRAS‐mutated colorectal carcinoma cells to cetuximab

Roberto Arriga, Sara Caratelli, Giulia Lanzilli et al. · International Journal of Cancer · 2019 · 28 citations · Full text

, , +17

Bone morphogenetic protein signaling regulates skin inflammation via modulating dendritic cell function

Tommaso Sconocchia, Mathias Hochgerner, Elke Schwarzenberger et al. · Journal of Allergy and Clinical Immunology · 2020 · 28 citations · Full text

, , +17

BMP7 aberrantly induced in the psoriatic epidermis instructs inflammation-associated Langerhans cells

Izabela Borek, René Köffel, Julia Feichtinger et al. · Journal of Allergy and Clinical Immunology · 2019 · 23 citations · Full text

, , +14

Human gene-engineered calreticulin mutant stem cells recapitulate MPN hallmarks and identify targetable vulnerabilities

Johannes Foßelteder, Gabriel Pabst, Tommaso Sconocchia et al. · Leukemia · 2023 · 19 citations · Full text

, , +17

1–5 of 7